View by Specialty

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

Pulmonary Vascular Disease News

SPONSORED CONTENT
Save
SPONSORED CONTENT
April 01, 2020
7 min read
Save

Clinical review of COVID-19 and CVD: What the cardiovascular practitioner needs to know

Clinical review of COVID-19 and CVD: What the cardiovascular practitioner needs to know

This summary reviews the evolving molecular and clinical data on COVID-19, with a focus on the intersection of this virus with CVD and its potential impact on patients with CV and professionals.

SPONSORED CONTENT
March 25, 2020
3 min read
Save

Cardiac injury confers greater mortality in patients with COVID-19

Cardiac injury confers greater mortality in patients with COVID-19

Among patients with laboratory-confirmed COVID-19 in Wuhan, China, those with cardiac injury had a higher risk for in-hospital mortality than patients without cardiac injury.

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

SPONSORED CONTENT
March 06, 2020
2 min read
Save

Top pulmonology news from February: FDA updates, noninvasive ventilation in COPD and more

Healio Pulmonology has you covered. The Editors have compiled a list of popular articles posted on Healio Pulmonology in February.

SPONSORED CONTENT
February 27, 2020
3 min read
Save

Gut bacteria linked to PAH

Gut bacteria linked to PAH

New data published in Hypertension have shown that a unique profile of gut bacteria can predict the presence of pulmonary artery hypertension in patients with 83% accuracy.

SPONSORED CONTENT
February 06, 2020
1 min read
Save

FDA grants breakthrough device designation for novel pulmonary hypertension system

FDA grants breakthrough device designation for novel pulmonary hypertension system

The FDA has granted breakthrough device designation for the Aria CV Pulmonary Hypertension System, according to a manufacturer press release.

SPONSORED CONTENT
January 28, 2020
1 min read
Save

Acceleron announces positive phase 2 trial results for PAH drug

Sotatercept met the primary and key secondary endpoints of the PULSAR phase 2 trial in patients with pulmonary artery hypertension, according to the press release from Acceleron Pharma.

SPONSORED CONTENT
January 15, 2020
2 min read
Save

Elevated pulmonary vascular resistance increases mortality risk after heart transplant

Elevated pulmonary vascular resistance increases mortality risk after heart transplant

Even with lower pulmonary artery pressures, elevated pulmonary vascular resistance is associated with worse survival after heart transplant, according to a recently published study.

SPONSORED CONTENT
January 09, 2020
3 min read
Save

Exercise pulmonary hypertension predicts CV, all-cause death

Exercise pulmonary hypertension predicts CV, all-cause death

Pulmonary hypertension that occurs during exercise was found to be associated with poor CV event-free survival for patients with chronic dyspnea who show no signs of pulmonary hypertension at rest.

SPONSORED CONTENT
December 23, 2019
2 min read
Save

Meeting highlights from 2019: Updates in asthma, COPD, PAH and more

Meeting highlights from 2019: Updates in asthma, COPD, PAH and more

Healio Pulmonology has you covered on some of the year’s top news from medical meetings. We bring you highlights from the American Thoracic Society International Conference and the CHEST Annual Meeting.

SPONSORED CONTENT
December 09, 2019
3 min read
Save

AHA: Geriatric syndromes affect care of older patients in cardiac ICU

AHA: Geriatric syndromes affect care of older patients in cardiac ICU

Despite older patients receiving the care they need in cardiac ICUs, they may experience worsening of geriatric conditions such as cognitive impairments and frailty, according to a American Heart Association scientific statement published in Circulation.

View more